This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Senju Pharmaceutical Co., Ltd., The University of Tokyo. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 229 
1 out of 1,356 
Years Active: 2019
Title: Tomohiko Usui: Innovator in Corneal Disorder Treatments
Introduction
Tomohiko Usui is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of ophthalmology, particularly in the treatment of corneal disorders. His innovative approach has led to the development of a unique agent aimed at preventing and treating various corneal conditions.
Latest Patents
Usui holds a patent for an agent designed for the prevention or treatment of corneal disorders. This invention specifically addresses issues such as corneal epithelial disorder, dry eye, and reduction in corneal sensitivity. The active ingredient in this agent is angiopoietin-like protein 7, which plays a crucial role in enhancing corneal health.
Career Highlights
Throughout his career, Tomohiko Usui has been associated with prestigious institutions, including The University of Tokyo. He has also worked with Senju Pharmaceutical Co., Ltd., where he has contributed to research and development in the pharmaceutical sector.
Collaborations
Usui has collaborated with Chiho Yabuta, further enhancing the impact of his work in the field of corneal health.
Conclusion
Tomohiko Usui's innovative contributions to the treatment of corneal disorders highlight his dedication to improving eye health. His work continues to influence the field and offers hope for those suffering from these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile